Krimo Bouabdallah

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

Steven Le Gouill, Catherine Thiéblemont, Lucie Obéric et al. · New England Journal of Medicine · 2017 · 398 citations · Full text

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma

Martin Dreyling, Armando Santoro, Luigina Mollica et al. · Journal of Clinical Oncology · 2017 · 386 citations

Immunology, Pathology, Pi3k Inhibitor +17

Graft-Versus-Lymphoma Effect for Aggressive T-Cell Lymphomas in Adults: A Study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire

Steven Le Gouill, Nöel Milpied, Agnès Buzyn et al. · Journal of Clinical Oncology · 2008 · 291 citations · Full text

Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study

Michael Wang, Javier Muñoz, André Goy et al. · Journal of Clinical Oncology · 2022 · 283 citations · Full text

Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma

M. Dreyling, Franck Morschhauser, Krimo Bouabdallah et al. · Annals of Oncology · 2017 · 267 citations · Full text